MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cpt.70502

Медицинская библиотека · Clinical pharmacology and therapeutics · 2026

Toward the Use of Real-World Data for Regulatory and HTA Decision-Making: Experiences and Recommendations from Six EU-Funded Projects.

Russek Martin, Peltner Jonas, Pfeifer Kerstin, Arvanitis Theodoros N, De Valck Dirk, de Vries Sieta T, Dumontier Michel, Ehrenstein Vera, El Hakouni Omaima, Epiphaniou Gregory, Ertaylan Gokhan, Fernandes Joana, Hansen Scott, Harrison Stuart, Horváth-Puhó Erzsébet, Islam Saif Ul, Kahri Pekka, Mader Julia K, Maple Carsten, Matragkas Nikolaos, Misra Shivani, Mol Peter G M, Paakinaho Anne, Pakarinen Sami, Radanović Martina, Reviers Evy, Sørensen Kathrine Kold, Spruit Marco, Tikka Christina, Tolppanen Anna-Maija, Torp-Pedersen Christian, Vela Mirna, Vo Thuan, Yazdanfard Puriya Daniel Würtz, Haenisch Britta

СтатьяОбзорПеревод в очереди

Аннотация

Real-world data are increasingly important for regulatory and health technology assessment decision-making, yet their effective use across Europe remains limited by technical, methodological, regulatory, and societal challenges. Drawing on the experiences of six Horizon Europe projects in the MetReal cluster, this review summarizes common barriers and emerging solutions for the use of real-world data in regulatory decision-making. Key challenges include complex and lengthy data access procedures, fragmented governance frameworks, variable data quality and completeness, limited interoperability, methodological difficulties in analyzing heterogeneous datasets, and infrastructure constraints within secure data environments. The article highlights opportunities to address these barriers through improved metadata, harmonization, federated analytics, synthetic data sandboxes, sustainable funding, and stronger collaboration between researchers, regulators, health technology assessment bodies, data holders, and citizens. These recommendations aim to strengthen Europe's health data ecosystem and support more robust, efficient, and trusted evidence generation for public health and patient benefit.

Для цитирования: Russek Martin, Peltner Jonas, Pfeifer Kerstin, Arvanitis Theodoros N, De Valck Dirk, de Vries Sieta T, Dumontier Michel, Ehrenstein Vera, El Hakouni Omaima, Epiphaniou Gregory, Ertaylan Gokhan, Fernandes Joana, Hansen Scott, Harrison Stuart, Horváth-Puhó Erzsébet, Islam Saif Ul, Kahri Pekka, Mader Julia K, Maple Carsten, Matragkas Nikolaos, Misra Shivani, Mol Peter G M, Paakinaho Anne, Pakarinen Sami, Radanović Martina, Reviers Evy, Sørensen Kathrine Kold, Spruit Marco, Tikka Christina, Tolppanen Anna-Maija, Torp-Pedersen Christian, Vela Mirna, Vo Thuan, Yazdanfard Puriya Daniel Würtz, Haenisch Britta. Toward the Use of Real-World Data for Regulatory and HTA Decision-Making: Experiences and Recommendations from Six EU-Funded Projects.. Clinical pharmacology and therapeutics. 2026. DOI: 10.1002/cpt.70502.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.